Human versus equine intramuscular antitoxin, with or without human intrathecal antitoxin, for the treatment of adults with tetanus: a 2 × 2 factorial randomised controlled trial. (2022)
Attributed to:
MRC Centre for Global Infectious Disease Analysis
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s2214-109x(22)00117-6
PubMed Identifier: 35561721
Publication URI: http://europepmc.org/abstract/MED/35561721
Type: Journal Article/Review
Volume: 10
Parent Publication: The Lancet. Global health
Issue: 6
ISSN: 2214-109X